Following the company’s fourth quarter results, Leede Financial analyst Douglas Loe has upgraded Cipher Pharmaceuticals.

Investors might want to bet on Zoom Communications (ZM), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

Raamdeo Agarwal emphasizes the power of compounding in stock markets, explaining CAGR, Rule of 72, and wealth-building ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended ...

Investment analysts at Morgan Stanley initiated coverage on shares of Gen Digital (NASDAQ:GEN – Get Free Report) in a research note issued to investors on Tuesday. The firm set an “equal weight” ...

You don’t have to fret that stock markets are down. Instead, use these losses for tax harvesting, and save on tax ...

Bayer's 2024 annual results showed a 2.2% sales decline, with only free cash flow improving significantly. Read why BAYZF ...

Steel stocks such as Tata Steel, JSW Steel, SAIL, Jindal Steel and NMDC are in focus today after the Directorate General of ...

Sebi's proposal for a gross limit in options by using the delta parameter has brokers and prop traders worried. They believe ...

TOKYO -- Nikkei said Wednesday it will change the price-adjustment factor applied to the shares of Zozo, a Japanese online ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

In this article, we will take a look into Meta Platforms Inc's (NASDAQ:META) DCF analysis, a reliable and data-driven ...